17th Annual Strategic Project & Portfolio Management for Pharma
With ongoing and ever tightened budget cuts, pharma companies are struggling to prioritise projects with limited R&D budget – whilst at the same time the patent cliff is drying up the product pipeline which will have immense aftermaths of the company’s revenue stream...